Brief: Insilico Medicine Cayman Topco Says Possible Participation In Establishment Of An Investment Fund
18/08/2026 16:22
BRIEF-Insilico Medicine Cayman Topco Says Possible Participation In Establishment Of An Investment Fund Aug 18 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK:
POSSIBLE PARTICIPATION IN ESTABLISHMENT OF AN INVESTMENT FUND
TO HOLD 60% OF RMB5 MILLION JOINT VENTURE CAPITAL
PROPOSED FUND TARGETS RMB1.01 BILLION FOR BIOPHARMACEUTICAL INVESTMENTS
Further company coverage: 3696.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7